French vote on bioethics slips in ban of DNA patents
This article was originally published in Clinica
The lower house of the French parliament, the Assemblee Nationale, has used its vote on the bioethics bill to introduce a surprise amendment banning the patentability of living beings. The amendment is specifically aimed at preventing patents on DNA sequences because of the fear among many experts in France that this could lead to monopolies on genes.
You may also be interested in...
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.